Fujihara, Kazuo
Palace, Jacqueline
Article History
First Online: 11 November 2014
Competing interests
: K.F. serves on scientific advisory boards for Alexion Pharmaceuticals, Bayer Schering Pharma, Biogen Idec, Chugai Pharmaceutical, Merck Serono, Mitsubishi Tanabe Pharma Corporation, Nihon Pharmaceutical, Novartis Pharma and Ono Pharmaceutical. He has received travel funding and speaker honoraria from Asahi Kasei Medical Co., Astellas Pharma Inc., Bayer Schering Pharma, Biogen Idec, Cosmic Corporation (a distributer of ELISA to detect aquaporin AQP4-IgG in Japan), Daiichi Sankyo, Eisai Inc., Mitsubishi Tanabe Pharma Corporation, Novartis Pharma and Takeda Pharmaceutical Company, Ltd; and research funding from Asahi Kasei Medical Co., Bayer Schering Pharma, Biogen Idec Japan, Eisai Inc., Kowa Pharmaceuticals America, Inc., Mitsubishi Tanabe Pharma Corporation, Teva Pharmaceutical K.K., Teijin Pharma, and The Chemo-Sero-Therapeutic Research Institute. J.P. has received conference funding for scientific meetings and honoraria for advisory work from Bayer Schering, Biogen Idec, Chugai Pharma, Merck Serono, Novartis, Ono Pharmaceutical Co. Ltd and Teva. She has received unrestricted research grants from Bayer Schering, Biogen Idec, Merck Serono and Novartis.